Suven Life Sciences Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1989. The current market capitalisation stands Rs 3605 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 530239. and also listed on National Stock Exchange (NSE) with NSE code as SUVEN.
Suven Life Sciences Limited, a biopharmaceutical company, manufactures and sells bulk drugs and intermediaries worldwide. It operates through Manufacturing, Services, and Research and Development segments. The manufactures bulk drugs and intermediates under contract manufacturing services. It also provides a range of drug discovery and development support services to pharma and biotech companies. Suven Life Sciences Limited focuses on discovering and developing new chemical entities in central nervous system therapies for the treatment of cognitive disorders, major depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, and gastro-intestinal motility disorders. The was formerly known as Suven Pharmaceuticals Pvt. Limited and changed its name to Suven Life Sciences Limited in 2003. Suven Life Sciences Limited was founded in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.